PQR-626

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NamePQR-626
Drug Alias NamePQR-626
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsmTOR Complex 2Mammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsTuberous Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPiqur Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesPiqur Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsTuberous Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A